The Department of Justice asked a federal court to dismiss Florida Agriculture Minister Nikki Fried’s lawsuit that seeks to allow medical marijuana users from buying and owning guns. The government’s argument? It would be too “dangerous to trust regular marijuana users to exercise sound judgment.”
Federal policy forces cardholders to choose between their state constitutional right to medicinal cannabis and federal their Second Amendment gun rights, said Fried when she announced the litigation in April at the Benzinga Cannabis Capital Conference in Miami Beach
The DOJ’s Logic?
The DOJ’s motion to dismiss essentially noted that gun rights are reserved for “law-abiding” people and, so long as cannabis is illegal at a federal level and has “no accepted medical use,” even Florida’s thousands of legal medical marijuana patients should not be allowed to possess guns.
Marijuana Moment, which first reported the news, noted that the DOJ drew parallels to past gun bans for groups like Native Americans, Catholics, panhandlers, those who refuse to take an oath of allegiance to the government and people who shoot firearms while drunk.
While the DOJ holds that federal law preempts state law and ignores the numerous medical conditions that qualify people to be MMJ patients, it also cites Florida’s law - including state policy that requires doctors to let patients know that medical marijuana may impair “judgment, cognition, and physical coordination,” as do many other drugs and certainly alcohol, pointed out Marijuana Moment.
Medical marijuana has been legal in Florida since 2014 under the
Compassionate Medical Cannabis Act.
Photo: Mohamed Hassan and Alexey Hulsov by Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.